期刊文献+

不同细胞培养基对抗破伤风毒素人源单抗关键质量属性的影响 被引量:1

Effects of different cell culture media on critical quality attributes of human monoclonal antibody against tetanus toxin
原文传递
导出
摘要 目的探讨不同培养基对抗破伤风毒素人源单抗工程细胞株生长状态及抗体关键质量属性的影响,筛选出适应抗破伤风毒素人源单抗工程细胞株的培养基。方法选取Growth A、Dynamis、T543种商用培养基,采用Fed-batch培养模式培养,观察活细胞密度及细胞活率;并通过SEC-HPLC和CE-SDS分析抗体纯度、cIEF法分析pI及电荷异构体。结果Growth A medium培养的细胞活细胞密度最高,细胞活率在Dynamis medium和T54 medium之间;Growth A medium培养的细胞抗体纯度最高;3种培养基培养的细胞抗体pI差异不明显;Growth A medium培养的细胞抗体电荷变异体酸性峰数量和占比均少于其他两种培养基,主峰占比在其他两种培养基之间。结论Growth A medium较适合抗破伤风毒素人源单抗工程细胞株的培养。 Objective To investigate the effects of different media on growth of engineered cell strain and critical quality attributes of human monoclonal antibody(McAb)against tetanus toxin and screen the optimal medium.Methods Three commercial culture media,Growth A,Dynamis and T54,were used in fed-batch model,and the cell viability and viable cell density were determined.The antibody purity were analyzed by SEC-HPLC and CE-SDS,while the isoelectric point and charge heterogeneity by cIEF method.Results The viable cell density in Growth A medium was higher than,while the cell viability rate was between,those in Dynamis and T54 media.The purity of McAb in Growth A medium was higher than those in the other two media.However,there was no significant difference in the PI values of McAbs cultured in the three media.The number and proportion of acid peak of charge variation of antibody cultured in Growth A medium were less than,while the proportion of main peak was between,those in the other two media.Conclusion Growth A medium is more suitable for the cultivation of engineered cells for McAb against tetanus toxin.
作者 王建锋 汪艳艳 郭岚 叶星 南建军 安晨 宋兰兰 陈继军 毛晓燕 WANG Jian-feng;WANG Yan-yan;GUO Lan;YE Xing;NAN Jian-jun;AN Chen;SONG Lan-lan;CHEN Ji-jun;MAO Xiao-yan(Lanzhou Institute of Biological Products,Co.,Ltd,Engineering Research Center of Macromolecules Biological Drugs of Gansu Province,Vaccinal Engineering Technology Research Center of Gansu Province,Lanzhou 730046,Gansu Province,China)
出处 《中国生物制品学杂志》 CAS CSCD 北大核心 2021年第11期1300-1306,共7页 Chinese Journal of Biologicals
基金 甘肃省科技重大专项(1502FKDA008)。
关键词 细胞培养基 破伤风毒素 单克隆抗体 质量属性 Cell culture medium Tetanus toxin Monoclonal antibody(McAb) Quality attributes
  • 相关文献

参考文献2

二级参考文献28

  • 1NA W, PARK N, YEOM M, et al. Ebola outbreak in Western Africa 2014: What is going on with Ebola virus?. Clin Exp Vaccine Res,2014,4(1): 17-22.
  • 2QIU X, WONG G, AUDET J, et al. Reversion of advanced Ebola virus disease in nonhuman primates with ZMapp. Nature,2014,514(7520): 47-53.
  • 3LIU S D, CHALOUNI C, YOUNG J C, et al. Afucosylated antibodies increase activation of FcgammaRIIIa-dependent signaling components to intensify processes promoting ADCC. Cancer Immunol Res,2015,3(2): 173-183.
  • 4KRAMSKI M, STRATOV I, KENT S J. The role of HIV-specific antibody-dependent cellular cytotoxicity in HIV prevention and the influence of the HIV-1 Vpu protein. Aids,2015,29(2): 137-144.
  • 5ANDERSON C L, WANG Y, RUSTANDI R R. Applications of imaged capillary isoelectric focussing technique in development of biopharmaceutical glycoprotein-based products. Electrophoresis,2012,33(11):1538-1544.
  • 6LIU L. Antibody glycosylation and its impact on the pharmacokinetics and pharmacodynamics of monoclonal antibodies and Fc-fusion proteins. J Pharm Sci,2015,104(6): 1866-1884.
  • 7SHI H H, GOUDAR C T. Recent advances in the understanding of biological implications and modulation methodologies of monoclonal antibody N-linked high mannose glycans. Biotechnol Bioeng,2014,111(10): 1907-1919.
  • 8FOLKMAN J. Tumor angiogenesis: therapeutic implications. [ J ]. N Engl J Med, 1971,285(21 ) :1182-1186.
  • 9ALAM D S, YUNUS M,EL AR1FEEN S, et al. Zinc tlatment for 5 or 10 days is equally efficacious in preventing diarrhea in the subsequent 3 months among Bangladeshi children [ J]. J Nutr, 2010, 141(2) :312-315.
  • 10KERBEL R S. Tumor angiogenesis [ J ]. N Engl J Med, 2008, 358(19) :2039-2049.

共引文献10

同被引文献24

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部